Literature DB >> 2865191

Effects of putative neurotransmitters on release of prolactin from pituitary glands of the domestic fowl co-incubated with hypothalamic tissue.

T R Hall, S Harvey, A Chadwick.   

Abstract

Pituitary glands and hypothalami from broiler fowl heads were incubated alone or together with histamine, gamma-aminobutyric acid (GABA) or acetylcholine (ACh) as well as with catecholamines or neurotransmitter antagonists. Histamine and ACh stimulated, whereas GABA inhibited, the hypothalamus-induced release of prolactin, responses blocked by their specific antagonists. The dopamine antagonist pimozide, but not adrenergic (both alpha and beta), serotoninergic or cholinergic antagonists, prevented the actions of histamine and GABA. None of the antagonists except the cholinergic blocker, atropine, affected ACh-induced release of prolactin. Neither histamine nor ACh prevented inhibition of prolactin release by dopamine or stimulation of prolactin release by noradrenaline. GABA did not affect the response to noradrenaline. Furthermore, histamine, GABA and ACh had no effects on thyrotrophin releasing hormone-stimulated release of prolactin directly at the pituitary level. These results suggest that histamine and GABA affect prolactin release from chicken pituitaries in vivo by modifying the activity of the dopaminergic system. Acetylcholine may stimulate the secretion of prolactin releasing factor from the hypothalamus.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2865191     DOI: 10.1016/0306-3623(85)90008-4

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  1 in total

1.  Peripheral Inhibitor of AChE, Neostigmine, Prevents the Inflammatory Dependent Suppression of GnRH/LH Secretion during the Follicular Phase of the Estrous Cycle.

Authors:  Andrzej P Herman; Janina Skipor; Agata Krawczyńska; Joanna Bochenek; Karolina Wojtulewicz; Hanna Antushevich; Anna Herman; Kamila Paczesna; Katarzyna Romanowicz; Dorota Tomaszewska-Zaremba
Journal:  Biomed Res Int       Date:  2017-08-15       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.